Alexandra Balcom
Fortuna: - $ al 30/09/2026
Fortuna: - $ al 30/09/2026
Alexandra Balcom is currently an Independent Director at Crescent Biopharma, Inc. since 2024.
Former roles include Director at Crescent Biopharma, Inc. (Old), Controller at Agios Pharmaceuticals, Inc., Vice President-Finance at SQZ Biotechnologies Co. from 2017 to 2021, and Chief Financial Officer & Treasurer at Nuvalent, Inc. from 2021 to 2026.
Education includes an MBA from Boston College and an undergraduate degree from the University of Massachusetts.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
-.--% | 02/06/2026 | 0 ( -.--% ) | - $ | 30/09/2026 |
| Empresas | Cargo | Inicio |
|---|
| Empresas | Cargo | Fin |
|---|---|---|
| NUVALENT, INC. | Director Financiero/CFO | 15/07/2026 |
| SQZ BIOTECHNOLOGIES COMPANY | Corporate Officer/Principal | 01/03/2021 |
| AGIOS PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
Agios Pharmaceuticals, Inc.
Agios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics | Health Technology |
SQZ Biotechnologies Co.
SQZ Biotechnologies Co. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops cell therapies for patients with cancer, infectious diseases and serious conditions | Health Technology |
Boston College
Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Massachusetts
University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nuvalent, Inc.
Nuvalent, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of targeted therapies for patients with cancer | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.